Department of Emergency Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei City, Anhui Province, China.
Hefei Emergency Center, Hefei City, Anhui Province, China.
BMC Health Serv Res. 2022 Apr 23;22(1):546. doi: 10.1186/s12913-022-07890-x.
There is uncertainty about the best approaches for advanced airway management (AAM) and the effectiveness of adrenaline treatments in Out-of-hospital cardiac arrest (OHCA). This study aimed to evaluate whether AAM and adrenaline administration provided by Emergency Medical Service (EMS) can improve the outcomes of OHCA.
This study was a prospective analysis of collected data based on OHCA adult patients treated by the EMS in China from January 2019 to December 2020.The patients were divided into AAM group and no AAM group, and into subgroups according to whether adrenaline was used. The outcome was rate of return of spontaneous circulation (ROSC), survival to admission and hospital discharge.
1533 OHCA patients were reported. The probability of ROSC outcome and survival admission in the AAM group was significantly higher, compared with no AAM group. The probability of ROSC outcome in the AAM group increased by 66% (adjusted OR: 1.66, 95%CI, 1.02-2.71). There were no significant differences in outcomes between the adrenaline and no adrenaline groups. The combined treatment of AAM and adrenaline increased the probability of ROSC outcome by 114% (adjusted OR, 2.14, 95%CI, 1.20-3.81) and the probability of survival to admission increased by 115% (adjusted OR, 2.15, 95%CI, 1.16-3.97).
The prehospital AAM and the combined treatment of AAM and adrenaline in OHCA patients are both associated with an increased rate of ROSC. The combined treatment of AAM and adrenaline can improve rate of survival to admission in OHCA patients.
在院外心脏骤停(OHCA)中,高级气道管理(AAM)和肾上腺素治疗的最佳方法以及疗效存在不确定性。本研究旨在评估急救医疗服务(EMS)进行的 AAM 和肾上腺素给药是否可以改善 OHCA 的结局。
这是一项基于中国 2019 年 1 月至 2020 年 12 月期间由 EMS 治疗的 OHCA 成年患者的前瞻性数据分析。患者分为 AAM 组和无 AAM 组,并根据是否使用肾上腺素进一步分为亚组。结局为自主循环恢复(ROSC)率、入院存活率和出院存活率。
共报告了 1533 例 OHCA 患者。与无 AAM 组相比,AAM 组的 ROSC 结局和入院存活率的可能性显著更高。AAM 组的 ROSC 结局可能性增加了 66%(调整后的 OR:1.66,95%CI,1.02-2.71)。肾上腺素组和无肾上腺素组的结局没有显著差异。AAM 和肾上腺素的联合治疗使 ROSC 结局的可能性增加了 114%(调整后的 OR,2.14,95%CI,1.20-3.81),并使入院存活率增加了 115%(调整后的 OR,2.15,95%CI,1.16-3.97)。
OHCA 患者院前 AAM 和 AAM 与肾上腺素联合治疗均与 ROSC 率增加相关。AAM 与肾上腺素联合治疗可提高 OHCA 患者的入院存活率。